Pathogenic germline variants associated with different HER2 expression among breast cancer patients

Keyphrases

• Breast Cancer Patients 100%
• HER2 Expression 100%
• Pathogenic Germline Variants 100%
• Breast Cancer 80%
• Pathogenic Variants 60%
• Clinical Outcomes 40%
• Human Epidermal Growth Factor Receptor 2 (HER2) 40%
• Higher Groups 40%
• HER2-zero 40%
• HER2-low 40%
• Chinese Breast Cancer Patients 40%
• Variant Distribution 40%
• Next-generation Sequencing 20%
• High-risk Individuals 20%
• Atypical Ductal Hyperplasia 20%
• Expression Level 20%
• Patient Risk 20%
• Associated Genes 20%
• Sequence Specificity 20%
• Blood Samples 20%
• Cancer Genes 20%
• Germline mutation 20%
• Neoadjuvant Therapy 20%
• Neoadjuvant Systemic Therapy 20%
• Early Detection System 20%
• Genetic Testing 20%
• Multigene 20%
• Germline Pathogenic Variant 20%
• Breast Cancer Family History 20%
• Multigene Panel 20%
• HER2-zero Breast Cancer 20%

Biochemistry, Genetics and Molecular Biology

• Germline 100%
• Germ Cell 100%
• Next Generation Sequencing 25%
• Genetic Screening 25%
• Germline Mutation 25%
• Expression Level 25%

Immunology and Microbiology

• Germ Cell 100%
• Genetic Screening 25%
• Germline Mutation 25%
• Next Generation Sequencing 25%